SLNO - SOLENO THERAPEUTICS INC

QQQ $ 476.00 $ 5.61 (1.19 %)

DIA $ 416.44 $ 2.30 (0.56 %)

SPY $ 563.62 $ 5.33 (0.95 %)

TLT $ 96.60 $ -1.04 (-1.07 %)

GLD $ 231.30 $ -1.66 (-0.71 %)

Previous Close

$ 48.95

Open

Bid

$ 48.91 x 100

Ask

$ 49.02 x 100

Day's Range

-- - --

52 Week Range

$ 3.69 - $ 53.82

Volume

475,543

Average Volume

Market Cap

1.9B

Beta (5Y Monthly)

$ 3.22

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-07-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	03-22-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-10-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-31-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	07-28-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	03-03-2021	12-31-2020	10-K
16	11-10-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-12-2020	03-31-2020	10-Q
19	03-04-2020	12-31-2019	10-K
20	11-13-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-13-2019	03-31-2019	10-Q
23	03-20-2019	12-31-2018	10-K
24	11-14-2018	09-30-2018	10-Q
25	08-14-2018	06-30-2018	10-Q
26	05-15-2018	03-31-2018	10-Q
27	04-02-2018	12-31-2017	10-K
28	11-14-2017	09-30-2017	10-Q
29	08-11-2017	06-30-2017	10-Q
30	05-11-2017	03-31-2017	10-Q
31	03-15-2017	12-31-2016	10-K
32	11-14-2016	09-30-2016	10-Q
33	08-12-2016	06-30-2016	10-Q
34	05-12-2016	03-31-2016	10-Q
35	03-25-2016	12-31-2015	10-K
36	11-12-2015	09-30-2015	10-Q
37	08-10-2015	06-30-2015	10-Q
38	05-04-2015	03-31-2015	10-Q
39	03-13-2015	12-31-2014	10-K
40	12-18-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

hain-celestial-posts-upbeat-q4-earnings-joins-soleno-therapeutics-energizer-holdings-and-other-big-stocks-moving-higher-on-tuesday

Hain Celestial Posts Upbeat Q4 Earnings, J...
08/27/2024 14:38:00

Soleno Therapeutics Announces FDA Acceptan...
08/27/2024 12:12:32

Oppenheimer Maintains Outperform on Soleno...
08/12/2024 12:06:30

Oppenheimer analyst Leland Gershell maintains Soleno Therapeutics (NASDAQ:SLNO) with a Outperform and raises the price targe...

Soleno Therapeutics Q2 EPS $(0.57) Beats $...
08/07/2024 20:34:20

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $...

Cantor Fitzgerald Reiterates Overweight on...
07/31/2024 15:54:35

Cantor Fitzgerald analyst Kristen Kluska reiterates Soleno Therapeutics (NASDAQ:SLNO) with a Overweight and maintains $67 pr...

Soleno Therapeutics Submits NDA To The U.S...
06/28/2024 12:02:36

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therape...

Soleno Therapeutics Set To Join Russell 30...
06/04/2024 12:26:17

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therape...

nvidia-is-up-186-from-a-year-ago-yet-these-7-stocks-have-more-than-doubled-their-returns-over-the-ai-chipmaker

Nvidia Is Up 186% From A Year Ago, Yet The...
05/29/2024 21:56:11

NVIDIA Corp. (NASDAQ:NVDA) has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance r...

Soleno Therapeutics Announces Oral Present...
05/22/2024 20:23:36

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therape...

Oppenheimer Maintains Outperform on Soleno...
05/13/2024 12:36:24

Oppenheimer analyst Leland Gershell maintains Soleno Therapeutics (NASDAQ:SLNO) with a Outperform and lowers the price targe...

Baird Initiates Coverage On Soleno Therape...
05/10/2024 09:19:10

Baird analyst Brian Skorney initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Outperform rating and announces P...

Soleno Therapeutics Q1 2024 Adj EPS $(0.59...
05/09/2024 21:19:42

Soleno Therapeutics (NASDAQ:SLNO) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of...

Reported Earlier, Soleno Therapeutics Pric...
05/03/2024 06:07:50

Soleno has also granted the underwriters a 30-day option to purchase up to 450,000 shares of common stock at the public offerin...

Soleno Therapeutics Announces Proposed Pub...
05/02/2024 20:41:22

Soleno Therapeutics, Inc. (NASDAQ:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical compan...

Soleno Therapeutics Announces Peer-Reviewe...
04/30/2024 12:15:19

Soleno Therapeutics, Inc. (Soleno) (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for ...

us-stocks-kick-off-the-week-in-the-green-tesla-rockets-on-chinas-fsd-approval-yen-rallies-whats-driving-markets-monday

US Stocks Kick Off The Week In The Green, ...
04/29/2024 18:14:53

U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events...

Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
04/29/2024 16:31:20

Tesla, Deciphera Pharmaceuticals, Heartlan...
04/29/2024 14:47:40

Soleno Therapeutics Receives Breakthrough ...
04/29/2024 12:02:15

First Ever Breakthrough Designation for a Drug Being Developed for PWSDesignation is Based on Data from the Phase 3 Program for...